Literature DB >> 2418429

Androgen-repressed messages in the rat ventral prostate.

M L Montpetit, K R Lawless, M Tenniswood.   

Abstract

Poly (A)+ RNA from the prostates of both intact and castrated rats was translated in a message-dependent reticulocyte lysate, and the translation products were electrophoresed on SDS/polyacrylamide gels. Fluorography of these gels showed the expected disappearance, after castration, of the prostate steroid-binding proteins as well as a number of other androgen-dependent proteins. Two major (Mr 40,000 and 45,000) and several minor proteins appeared in the translation products of the castrated rat prostate RNA. Criss-cross liquid hybridization analysis between prostate poly (A+) RNA from intact and castrated rats also showed the disappearance of the abundant prostate steroid-binding protein sequences after castration and the synthesis of several new low to medium abundance sequences. Northern hybridization experiments demonstrated the presence of at least two, and possibly four androgen-repressed poly (A)+ RNA sequences. The most prominent of these, an RNA of 2,000 nucleotides, appeared within 2 days of castration, reaching a maximum on day 4 at a level approximately 400 times greater than the normal level. The other major sequence (a sequence of 1,000 nucleotides) appears after 4 days, reaching a peak between days 8 and 11. Sequences similar to these new RNAs could play an important role in the long-term resistance of prostatic cancer to hormone therapy in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418429     DOI: 10.1002/pros.2990080105

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  30 in total

Review 1.  Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin E Gleave; Toby Zellweger; Kim Chi; Hideaki Miyake; Satoshi Kiyama; Laura July; Simon Leung
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

Review 2.  Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview.

Authors:  A H Wyllie
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 3.  Androgens and prostate cancer.

Authors:  Alan I So; Antonio Hurtado-Coll; Martin E Gleave
Journal:  World J Urol       Date:  2003-10-29       Impact factor: 4.226

Review 4.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

5.  The role of stress proteins in prostate cancer.

Authors:  Alan So; Boris Hadaschik; Richard Sowery; Martin Gleave
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

6.  Chromosome assignments of the genes for glucocorticoid receptor, myelin basic protein, leukocyte common antigen, and TRPM2 in the rat.

Authors:  A Goldner-Sauvé; C Szpirer; J Szpirer; G Levan; D L Gasser
Journal:  Biochem Genet       Date:  1991-06       Impact factor: 1.890

7.  Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.

Authors:  Amina Zoubeidi; Kim Chi; Martin Gleave
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

8.  Genes regulated by androgen in the rat ventral prostate.

Authors:  Z Wang; R Tufts; R Haleem; X Cai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 9.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

Review 10.  Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.

Authors:  B Shannan; M Seifert; D A Boothman; W Tilgen; J Reichrath
Journal:  J Mol Histol       Date:  2006-09-19       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.